Dr Lalchandani Labs Limited

Equities

DLCL6

INE871Z01013

Healthcare Facilities & Services

Market Closed - Bombay S.E. 06:00:51 2024-05-10 am EDT 5-day change 1st Jan Change
21 INR +5.00% Intraday chart for Dr Lalchandani Labs Limited +6.06% -1.08%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Dr Lalchandani Labs Limited Approves Appointment of Namita Anand as Company Secretary and Compliance Officer CI
Dr Lalchandani Labs Limited Announces Resignation of Karan Kumar as Company Secretary and Compliance Officer CI
Dr Lalchandani Labs Limited Announces the Resignation of Archana R Jha as Company Secretary and Compliance Officer CI
Dr Lalchandani Labs Limited Approves Resignation of Monika Joshi as Company Secretary and Compliance Officer CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Dr Lalchandani Labs Limited Announces Resignation of Archana Jha from the Office of Company Secretary CI
Dr Lalchandani Labs Limited Appoints Monika Joshi as Company Secretary and Compliance Officer, Effective August 27, 2023 CI
Dr Lalchandani Labs Limited Announces Resignation of Archana R Jha as Company Secretary CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Dr Lalchandani Labs Limited Announces Management Changes CI
Dr Lalchandani Labs Limited Appoints Archana Jha as Company Secretary & Compliance Officer CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2022 CI
Dr Lalchandani Labs Limited Announces Resignation of CS Swati Poddar as Company Secretary and Compliance Officer CI
Dr Lalchandani Labs Limited Resumes in Full Capacity At the Lab in Punjabi Bagh CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Dr Lalchandani Labs to Provide Diagnostic Services in Delhi, India, as Part of New Deal MT
Dr Lalchandani Labs Limited Appoints Swati Chandra as Additional Director CI
Dr Lalchandani Labs Limited Announces Resignation of Ms. Manica Gupta as Non-Executive Director CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2021 CI
Dr Lalchandani Labs' : Net Profit Soars in Fiscal Q4 MT
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2021 CI
880,000 Equity Shares of Dr Lalchandani Labs Limited are subject to a Lock-Up Agreement Ending on 9-MAY-2021. CI
Dr Lalchandani Labs : Gets Approval to be Listed as COVID-19 Vaccination Center MT
Dr Lalchandani Labs Limited Announces Unaudited Earnings Results for the Half Year Ended September 30, 2020 CI
Dr Lalchandani Labs Limited Announces Increase in Capacity for Covid-19 RT-PCR Testing CI
Chart Dr Lalchandani Labs Limited
More charts
Dr Lalchandani Labs Limited is an India-based company, which is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. Through its integrated network, the Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The Company has its own blood banking services through its sister concern CPC blood bank. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
More about the company
  1. Stock Market
  2. Equities
  3. DLCL6 Stock
  4. News Dr Lalchandani Labs Limited
  5. Dr Lalchandani Labs : Gets Approval to be Listed as COVID-19 Vaccination Center
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW